000 01315 a2200385 4500
005 20250515165142.0
264 0 _c20090702
008 200907s 0 0 eng d
022 _a1557-9190
024 7 _a10.3816/CLM.2009.n.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVarghese, Abraham M
245 0 0 _aAssessment of bone marrow response in Waldenström's macroglobulinemia.
_h[electronic resource]
260 _bClinical lymphoma & myeloma
_cMar 2009
300 _a53-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBone Marrow
_xpathology
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aImmunoglobulin M
_xblood
650 0 4 _aImmunohistochemistry
650 0 4 _aMale
650 0 4 _aVidarabine
_xadministration & dosage
650 0 4 _aWaldenstrom Macroglobulinemia
_xblood
700 1 _aRawstron, Andy C
700 1 _aAshcroft, A John
700 1 _aMoreton, Paul
700 1 _aOwen, Roger G
773 0 _tClinical lymphoma & myeloma
_gvol. 9
_gno. 1
_gp. 53-5
856 4 0 _uhttps://doi.org/10.3816/CLM.2009.n.013
_zAvailable from publisher's website
999 _c18795406
_d18795406